Live Breaking News & Updates on Biopharmaceuticals

Stay updated with breaking news from Biopharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viking Therapeutics' stock soars 61% premarket after company reports positive results in trial of weight-loss drug

Viking posted positive results from a mid-stage trial of its GLP-1 drug. ....

Drug-administration , Therapeutics-inc , Viking-therapeutics , Article-normal , Biotechnology , Pharmaceuticals , Machinery , Agricultural-machinery , Health-care , Biopharmaceuticals , Specialized-drugs-medications

Amgen, Chevron share losses lead Dow's 110-point fall

Shares of Amgen and Chevron are trading lower Tuesday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of Amgen and Chevron. ....

Chevron , Amgen , Dow-jones-industrial-average , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Us-djia , Amgen-inc , Us-amgn

Automation in Biopharma Industry Propels Market Growth with

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) The ....

Dublin , Ireland , United-states , America , Siemens-healthineers , Rheosense-inc , Analytical-technology , Emerson-electric-co , Baumueller-nuermont-corp , Ametek-inc , Automation-software , Autodesk-inc

Minerva Neurosciences Shares Slide on Latest FDA Roluperidone Setback

By Colin Kellaher Minerva Neurosciences shares lost more than half of their value in early trading Tuesday after the U.S. Food and Drug Administration once. ....

Minerva-neurosciences , Colin-kellaher , Drug-administration , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Regulation-government-policy , Financial-performance , Share-price-movement-disruptions , New-products-services

Verve Therapeutics Shares Gain 16% On 4Q Revenue Beat

By Ben Glickman Shares of Verve Therapeutics rose Tuesday after fourth-quarter collaboration revenue came in ahead of expectations. The stock was up 16% to. ....

Boston , Massachusetts , United-states , Sekar-kathiresan , Ben-glickman , Eli-lilly , Vertex-pharmaceuticals , Verve-therapeutics , Executive-sekar-kathiresan , Article-normal , Biotechnology-services , Pharmaceuticals